Skip to main content
. 2023 Nov 1;27:418. doi: 10.1186/s13054-023-04712-2

Table 3.

Subgroup analysis of 30-day clinical success according to source of infection

30-day clinical success Cefoxitin
n = 63 (57%)
Carbapenem
n = 47 (43%)
OR (95% CI) p value
Source of bacteremia
 Central line associated 20/24 (83%) 10/12 (83%) 1.0 (0.1–8.5) 1.00
 Pneumonia 1/7 (14%) 3/14 (21%) 0.6 (0.1–10.0) 1.00
 Urinary tract 8/13 (61%) 2/3 (67%) 0.8 (0.1–19.7) 1.00
 Intra-abdominal 2/8 (25%) 1/4 (25%) 1.0 (0.1–78.4) 1.00
 Unknown 4/8 (50%) 7/9 (78%) 0.3 (0.2–3.4) .335

Data are presented as count (%). OR = odd ratio